ZBTB7A and prostate carcinoma: Zbtb7a (also known as pokemon) has been recently reported as an oncosuppressor in PCa since it is lost in a subset of human advanced prostate cancer and facilitates the oncogenic activity of SOX9 during prostate tumorigenesis favoring senescence bypass, increase of proliferation rate, apoptosis resistance, and invasive potential [71].